Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia.
about
Intraductal Carcinoma of the Prostate Gland: Recent AdvancesCurrent concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ systemIntraductal carcinoma of prostate (IDC-P): from obscure to significantGenetic profiling to determine risk of relapse-free survival in high-risk localized prostate cancer.Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer.Characterization of Heterogeneous Prostate Tumors in Targeted Pten Knockout Mice.Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.Identification of Combinatorial Genomic Abnormalities Associated with Prostate Cancer Early Recurrence.Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity.A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.CBP loss cooperates with PTEN haploinsufficiency to drive prostate cancer: implications for epigenetic therapy.An Updated Review of Cribriform Carcinomas with Emphasis on Histopathological Diagnosis and Prognostic Significance.Intraductal carcinoma of prostate: a comprehensive and concise review.ERG protein expression as a biomarker of prostate cancer.Biopsy sampling and histopathological markers for diagnosis of prostate cancer.Intraductal carcinoma of the prostate: a comprehensive and updated review.Intraductal Carcinoma of the Prostate on Diagnostic Needle Biopsy Predicts Prostate Cancer Mortality: A Population-Based Study.Histopathology of Prostate Cancer.Incidence of intraductal carcinoma, multifocality and bilateral significant disease in radical prostatectomy specimens from Japan and United States.Histopathological features of intra-ductal carcinoma of prostatic and high grade prostatic intraepithelialneoplasia and correlation with PTEN and P63.PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas.Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusionERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma.Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy.Mucinous and secondary tumors of the prostate.Reply to 'Low-grade intraductal carcinoma of the prostate: an idea whose time has not yet come': evidence-based medicine suggests that the time is now.Atypical intraductal proliferation and intraductal carcinoma of the prostate on core needle biopsy: a comparative clinicopathological and molecular study with a proposal to expand the morphological spectrum of intraductal carcinoma.High-grade prostatic intraepithelial neoplasia, PIN-like carcinoma, ductal carcinoma, and intraductal carcinoma of the prostate.Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification.Withaferin A Inhibits Prostate Carcinogenesis in a PTEN-deficient Mouse Model of Prostate Cancer.[Intraductal carcinoma of the prostate].The presence and clinical implication of intraductal carcinoma of prostate in metastatic castration resistant prostate cancer.
P2860
Q26741227-00E22D39-BA1F-49DA-A3E6-9D42E46A1F1DQ26748510-396C1AAB-BDCA-4EE0-8723-63E8570BEE4EQ26752918-A7475268-9D7E-44A9-BF2B-D87CF01CE0EEQ30573750-992DFB78-7FEF-4435-8646-5B8A2CC5B6B5Q35854235-C1C68273-A2A2-43A8-BFFA-81D7D139B1F0Q35903128-068FEBAD-E6D4-46A2-B195-3DF3E5F92C41Q36469889-1BD9755E-DFEB-4218-8F99-DC0D92730A98Q36753720-DC93E7E0-14D2-475D-B00B-BA16066F9B7FQ36774477-FEAADBC8-2420-4710-830E-7FD32FF4D0B5Q36887707-8D03C3E6-E2C3-4DB7-AA4B-A4A41C10E880Q37684550-3A199FAF-DE5A-407C-93D9-A0C6747D3AAAQ37720243-A6799610-80F1-4070-B42F-4FC622CDE272Q38134734-D1DFABC1-E595-4C8B-9FFF-DDE792C852B6Q38165243-D51F333E-16E5-4400-85F9-8F1B120D764DQ38256309-7F5AACBF-7D2C-4F2C-8370-5B7700073341Q38264005-0D6BA4B4-9CB3-47E2-B007-203BBAC8BD6BQ38940179-461686C6-15CF-45D7-85A4-2C080C776BC6Q39227648-4A1E4123-3C09-47AA-ACCE-B966E178DDAEQ39245025-E683F0A3-B530-4626-B6D8-A40CCBE454ACQ40236945-9D18625E-010B-4A0C-8FB5-29007B89107CQ41907553-165FB75F-9D0A-400E-AAEF-A26C39FD9159Q42119481-4E4257BD-3CA3-4072-A920-703B9D24D0F6Q42363171-D7EEF1D7-5DF7-45BA-A1B8-061A03B60D53Q43104641-9AEBC4AE-B2BB-41E7-A76B-D2CC23634678Q47664729-565D1C09-6186-42F8-B6E6-7BED993FCC31Q48188376-CE77B598-9F0C-4D06-BD75-3BA0429CE155Q48344410-17487DA3-9935-44C1-906B-3642F8C90A77Q49347835-5FC528E6-A4C5-4793-B24D-AD2FDC3593D2Q52629153-B95E2C5D-D4F6-4481-B94D-03A4F8C2CD20Q52870570-31A2A0E9-08D2-465C-9AC4-10BB91D126DFQ53194560-D385EDFA-B6D5-4447-AE3B-49A476AEB093Q53527594-2B8F8F6D-4AE4-46AA-9959-087DC097A1AB
P2860
Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cytoplasmic PTEN protein loss ...... tic intraepithelial neoplasia.
@ast
Cytoplasmic PTEN protein loss ...... tic intraepithelial neoplasia.
@en
type
label
Cytoplasmic PTEN protein loss ...... tic intraepithelial neoplasia.
@ast
Cytoplasmic PTEN protein loss ...... tic intraepithelial neoplasia.
@en
prefLabel
Cytoplasmic PTEN protein loss ...... tic intraepithelial neoplasia.
@ast
Cytoplasmic PTEN protein loss ...... tic intraepithelial neoplasia.
@en
P2093
P2860
P1433
P1476
Cytoplasmic PTEN protein loss ...... tic intraepithelial neoplasia.
@en
P2093
Angelo M De Marzo
Berrak Gumuskaya
Brian D Robinson
Hameed Rahimi
Jessica L Hicks
Jonathan I Epstein
Tsuyoshi Iwata
P2860
P2888
P304
P356
10.1038/MODPATHOL.2012.201
P577
2012-12-07T00:00:00Z